300869 康泰医学
已收盘 04-10 15:00:00
资讯
新帖
简况
康泰医学:各项整改工作正在有序推进中
证券之星 · 04-10 09:00
康泰医学:各项整改工作正在有序推进中
康泰医学新注册《CA20M呼气末二氧化碳监测仪软件V1.0》项目的软件著作权
证券之星 · 04-04
康泰医学新注册《CA20M呼气末二氧化碳监测仪软件V1.0》项目的软件著作权
康泰医学(300869)披露持股5%以上股东权益变动提示性公告,4月3日股价下跌3.03%
证券之星 · 04-03
康泰医学(300869)披露持股5%以上股东权益变动提示性公告,4月3日股价下跌3.03%
康泰医学(300869)披露股东询价转让定价情况提示性公告,3月26日股价下跌1.72%
证券之星 · 03-26
康泰医学(300869)披露股东询价转让定价情况提示性公告,3月26日股价下跌1.72%
康泰医学(300869.SZ)股东王桂丽拟询价转让3.74%股份
智通财经 · 03-25
康泰医学(300869.SZ)股东王桂丽拟询价转让3.74%股份
康泰医学(300869)披露公司产品获得CE证书公告,3月2日股价下跌3.04%
证券之星 · 03-02
康泰医学(300869)披露公司产品获得CE证书公告,3月2日股价下跌3.04%
康泰医学(300869)披露关于使用闲置自有资金进行现金管理的公告,2月26日股价下跌1.96%
证券之星 · 02-26
康泰医学(300869)披露关于使用闲置自有资金进行现金管理的公告,2月26日股价下跌1.96%
康泰医学(300869)披露2025年度业绩预亏公告,2月4日股价上涨0.32%
证券之星 · 02-04
康泰医学(300869)披露2025年度业绩预亏公告,2月4日股价上涨0.32%
康泰医学(300869)披露2025年度业绩预告,1月30日股价下跌1.34%
证券之星 · 01-30
康泰医学(300869)披露2025年度业绩预告,1月30日股价下跌1.34%
康泰医学(300869)披露2025年第四季度可转换公司债券转股情况,1月5日股价上涨4.27%
证券之星 · 01-05
康泰医学(300869)披露2025年第四季度可转换公司债券转股情况,1月5日股价上涨4.27%
科力装备:为康泰医学开发额温枪部件
证券之星 · 2025-12-01
科力装备:为康泰医学开发额温枪部件
康泰医学(300869)披露迪拜子公司成立进展,11月26日股价上涨0.06%
证券之星 · 2025-11-26
康泰医学(300869)披露迪拜子公司成立进展,11月26日股价上涨0.06%
11月24日康泰医学发布公告,股东减持81.66万股
证券之星 · 2025-11-24
11月24日康泰医学发布公告,股东减持81.66万股
康泰医学:11月20日高管杨志山、郑敏、寇国治、许云龙减持股份合计4000股
证券之星 · 2025-11-21
康泰医学:11月20日高管杨志山、郑敏、寇国治、许云龙减持股份合计4000股
康泰医学:11月19日高管寇国治减持股份合计5.9万股
证券之星 · 2025-11-20
康泰医学:11月19日高管寇国治减持股份合计5.9万股
康泰医学:11月18日高管寇国治、付春元减持股份合计42万股
证券之星 · 2025-11-19
康泰医学:11月18日高管寇国治、付春元减持股份合计42万股
康泰医学:11月14日高管付春元减持股份合计2万股
证券之星 · 2025-11-17
康泰医学:11月14日高管付春元减持股份合计2万股
康泰医学:11月12日高管付春元减持股份合计4.48万股
证券之星 · 2025-11-13
康泰医学:11月12日高管付春元减持股份合计4.48万股
康泰医学:11月10日高管付春元减持股份合计5万股
证券之星 · 2025-11-11
康泰医学:11月10日高管付春元减持股份合计5万股
康泰医学:11月7日高管付春元减持股份合计4万股
证券之星 · 2025-11-10
康泰医学:11月7日高管付春元减持股份合计4万股
加载更多
公司概况
公司名称:
康泰医学系统(秦皇岛)股份有限公司
所属行业:
专用设备制造业
上市日期:
2020-08-24
主营业务:
康泰医学系统(秦皇岛)股份有限公司的主营业务是医疗诊断、监护设备的研发、生产和销售。公司的主要产品是院线类产品、家用类产品、其他类产品。截至报告期末,公司及子公司共获得国内外有效专利484项,计算机软件著作权369项以及大量的技术储备。研发创新能力已经成为公司的核心竞争力之一。2025年4月,由河北工业大学牵头,复旦大学、燕山大学、康泰医学联合完成的“具身运动康复智能装备关键技术与应用”项目成果获得2024年度河北省科技进步奖一等奖。
发行价格:
10.16
{"stockData":{"symbol":"300869","market":"SZ","secType":"STK","nameCN":"康泰医学","latestPrice":13.36,"timestamp":1775804625000,"preClose":13.18,"halted":0,"volume":3348554,"delay":0,"changeRate":0.0137,"floatShares":264000000,"shares":401999999,"eps":-0.1952,"marketStatus":"已收盘","change":0.18,"latestTime":"04-10 15:00:00","open":13.28,"high":13.55,"low":13.28,"amount":44896300,"amplitude":0.0205,"askPrice":13.37,"askSize":688,"bidPrice":13.36,"bidSize":248,"shortable":0,"etf":0,"ttmEps":-0.1952,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1776043800000},"marketStatusCode":5,"adr":0,"adjPreClose":13.18,"symbolType":"stock","openAndCloseTimeList":[[1775784600000,1775791800000],[1775797200000,1775804400000]],"highLimit":14.5,"lowLimit":11.86,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":401803327,"isCdr":false,"pbRate":3.05,"roa":"--","roe":"0.52%","epsLYR":-0.19,"committee":-0.214653,"marketValue":5368000000,"turnoverRate":0.0127,"status":0,"floatMarketCap":3529000000},"requestUrl":"/m/hq/s/300869","defaultTab":"news","newsList":[{"id":"2626154508","title":"康泰医学:各项整改工作正在有序推进中","url":"https://stock-news.laohu8.com/highlight/detail?id=2626154508","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626154508?lang=zh_cn&edition=full","pubTime":"2026-04-10 09:00","pubTimestamp":1775782858,"startTime":"0","endTime":"0","summary":"证券之星消息,康泰医学(300869)04月09日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘请问什么时候才能解除FDA警告信?康泰医学回复:尊敬的投资者您好!公司收到FDA警告信后,已在规定时间内向FDA提交了正式回复及整改计划,各项整改工作正在有序推进中,公司与FDA始终保持着密切沟通,争取尽快关闭警告信。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041000007702.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624669977","title":"康泰医学新注册《CA20M呼气末二氧化碳监测仪软件V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2624669977","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624669977?lang=zh_cn&edition=full","pubTime":"2026-04-04 02:05","pubTimestamp":1775239517,"startTime":"0","endTime":"0","summary":"证券之星消息,近日康泰医学新注册了《CA20M呼气末二氧化碳监测仪软件V1.0》项目的软件著作权。今年以来康泰医学新注册软件著作权5个,较去年同期减少了95.61%。结合公司2025年中报财务数据,2025上半年公司在研发方面投入了4648.11万元,同比减17.08%。通过天眼查大数据分析,康泰医学系统(秦皇岛)股份有限公司共对外投资了7家企业,参与招投标项目472次;财产线索方面有商标信息85条,专利信息663条,著作权信息430条;此外企业还拥有行政许可275个。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040400000562.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","159180","300869"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624465486","title":"康泰医学(300869)披露持股5%以上股东权益变动提示性公告,4月3日股价下跌3.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624465486","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624465486?lang=zh_cn&edition=full","pubTime":"2026-04-03 18:34","pubTimestamp":1775212455,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘,康泰医学报收于13.1元,较前一交易日下跌3.03%,最新总市值为52.64亿元。该股当日开盘13.45元,最高13.58元,最低13.07元,成交额达4212.95万元,换手率为1.21%。近日,康泰医学披露《股东询价转让结果报告书暨持股5%以上股东持有权益比例降至5%以下的提示性公告》。公告显示,公司持股5%以上股东王桂丽通过集中竞价、大宗交易及询价转让方式减持公司股份,合计持股比例由10.00%下降至4.9999%,持股比例降至5%以下。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040300035794.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622691869","title":"康泰医学(300869)披露股东询价转让定价情况提示性公告,3月26日股价下跌1.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622691869","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622691869?lang=zh_cn&edition=full","pubTime":"2026-03-26 22:35","pubTimestamp":1774535718,"startTime":"0","endTime":"0","summary":"截至2026年3月26日收盘,康泰医学报收于13.11元,较前一交易日下跌1.72%,最新总市值为52.68亿元。康泰医学系统(秦皇岛)股份有限公司于2026年3月26日发布《股东询价转让定价情况提示性公告》。本次拟转让股份已获全额认购,初步确定受让方为15家机构投资者,受让股份总数为15,037,100股。本次转让不通过二级市场进行,受让方6个月内不得转让所受让股份。本次转让不涉及公司控制权变更。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032600044705.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622026022","title":"康泰医学(300869.SZ)股东王桂丽拟询价转让3.74%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2622026022","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622026022?lang=zh_cn&edition=full","pubTime":"2026-03-25 17:01","pubTimestamp":1774429292,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康泰医学(300869.SZ)发布股东询价转让计划书,拟参与公司首发前股东询价转让的股东为王桂丽,出让方拟转让股份的总数为1503.71万股,占公司当前总股本的比例为3.74%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1418739.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0251","300869"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616415356","title":"康泰医学(300869)披露公司产品获得CE证书公告,3月2日股价下跌3.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616415356","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616415356?lang=zh_cn&edition=full","pubTime":"2026-03-02 23:15","pubTimestamp":1772464518,"startTime":"0","endTime":"0","summary":"截至2026年3月2日收盘,康泰医学报收于14.66元,较前一交易日下跌3.04%,最新总市值为58.9亿元。该股当日开盘14.9元,最高14.96元,最低14.66元,成交额达5810.6万元,换手率为1.55%。康泰医学系统(秦皇岛)股份有限公司于近日取得由TV SD Product Service GmbH签发的CE证书,产品名称为Insect bite helper,注册分类为IIa类。该产品获得CE证书表明其符合欧盟相关要求,已具备进入欧盟市场的准入条件,对公司未来经营将产生积极影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030200040462.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300869"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614023838","title":"康泰医学(300869)披露关于使用闲置自有资金进行现金管理的公告,2月26日股价下跌1.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614023838","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614023838?lang=zh_cn&edition=full","pubTime":"2026-02-26 22:36","pubTimestamp":1772116580,"startTime":"0","endTime":"0","summary":"截至2026年2月26日收盘,康泰医学报收于15.03元,较前一交易日下跌1.96%,最新总市值为60.39亿元。康泰医学系统(秦皇岛)股份有限公司于2026年2月26日召开第四届董事会第二十五次会议,审议通过《关于使用闲置自有资金进行现金管理的议案》,同意公司使用总额度不超过人民币2亿元(含本数)的闲置自有资金进行现金管理,期限自董事会审议通过之日起12个月内有效,资金可循环滚动使用。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022600037375.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300869"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608410398","title":"康泰医学(300869)披露2025年度业绩预亏公告,2月4日股价上涨0.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608410398","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608410398?lang=zh_cn&edition=full","pubTime":"2026-02-04 22:39","pubTimestamp":1770215959,"startTime":"0","endTime":"0","summary":"截至2026年2月4日收盘,康泰医学报收于15.58元,较前一交易日上涨0.32%,最新总市值为62.6亿元。该股当日开盘15.53元,最高15.6元,最低15.38元,成交额达4986.38万元,换手率为1.27%。近日,康泰医学系统(秦皇岛)股份有限公司披露《2025年度业绩预告》。业绩变动主要原因为2025年度计提存货减值准备金额较上年减少,导致同比减亏。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020400041788.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607853042","title":"康泰医学(300869)披露2025年度业绩预告,1月30日股价下跌1.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607853042","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607853042?lang=zh_cn&edition=full","pubTime":"2026-01-30 23:13","pubTimestamp":1769785992,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘,康泰医学报收于15.43元,较前一交易日下跌1.34%,最新总市值为62亿元。该股当日开盘15.65元,最高15.8元,最低15.36元,成交额达7239.53万元,换手率为1.84%。康泰医学系统(秦皇岛)股份有限公司于近日披露《2025年度业绩预告》。本期业绩变动主要因计提存货减值准备金额较上年减少。本次业绩预告未经会计师事务所审计,最终数据以2025年度报告为准。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026013000048124.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601838816","title":"康泰医学(300869)披露2025年第四季度可转换公司债券转股情况,1月5日股价上涨4.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601838816","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601838816?lang=zh_cn&edition=full","pubTime":"2026-01-05 23:09","pubTimestamp":1767625754,"startTime":"0","endTime":"0","summary":"截至2026年1月5日收盘,康泰医学报收于15.64元,较前一交易日上涨4.27%,最新总市值为62.84亿元。该股当日开盘14.99元,最高15.65元,最低14.98元,成交额达1.08亿元,换手率为2.74%。近日,康泰医学系统(秦皇岛)股份有限公司发布关于2025年第四季度可转换公司债券转股情况的公告。公告显示,2025年第四季度,共有1张“康医转债”完成转股,票面金额100元,合计转为3股“康泰医学”股票。公司总股本因转股增加3股,其他股份未发生变化。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500040953.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2588741006","title":"科力装备:为康泰医学开发额温枪部件","url":"https://stock-news.laohu8.com/highlight/detail?id=2588741006","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588741006?lang=zh_cn&edition=full","pubTime":"2025-12-01 15:04","pubTimestamp":1764572659,"startTime":"0","endTime":"0","summary":"证券之星消息,科力装备12月01日在投资者关系平台上答复投资者关心的问题。财报显示贵司积极拓展医疗器械(额温枪)等非汽车零部件领域。2020 年初,外部不利因素的出现,医疗器械企业康泰医学的额温枪产品供不应求,其原有额温枪结构件供应商产能难以支撑爆发式增长的订单。公司应康泰医学的紧急求助,为其开发模具和生产额温枪整体结构部件和脉搏血氧仪壳体部件。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120100012186.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251","BK0264","301552"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2586258897","title":"康泰医学(300869)披露迪拜子公司成立进展,11月26日股价上涨0.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586258897","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586258897?lang=zh_cn&edition=full","pubTime":"2025-11-26 17:48","pubTimestamp":1764150515,"startTime":"0","endTime":"0","summary":"截至2025年11月26日收盘,康泰医学报收于16.68元,较前一交易日上涨0.06%,最新总市值为67.02亿元。该股当日开盘16.65元,最高17.27元,最低16.61元,成交额达9238.99万元,换手率为2.15%。公司近日发布公告称,其在迪拜设立子公司的事项已取得新进展。根据公告,康泰医学系统(秦皇岛)股份有限公司已于近期完成子公司CONTEC GLOBAL INVESTMENT FZCO的注册并取得贸易许可证。此次对外投资事项已于2025年7月14日经公司第四届董事会第二十次会议审议通过。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112600027003.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300869"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2585619054","title":"11月24日康泰医学发布公告,股东减持81.66万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2585619054","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585619054?lang=zh_cn&edition=full","pubTime":"2025-11-24 20:01","pubTimestamp":1763985671,"startTime":"0","endTime":"0","summary":"证券之星消息,11月24日康泰医学发布公告《康泰医学:关于持股5%以上股东、部分董事及高级管理人员减持计划实施完毕的公告》,其股东王桂丽于2025年10月16日至2025年11月24日间合计减持81.66万股,占公司目前总股本的0.2032%,变动期间该股股价上涨1.47%,截止11月24日收盘报16.56元。股东增减持详情见下表:根据康泰医学2025年三季报公布的十大股东详情如下:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112400030272.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2585439241","title":"康泰医学:11月20日高管杨志山、郑敏、寇国治、许云龙减持股份合计4000股","url":"https://stock-news.laohu8.com/highlight/detail?id=2585439241","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585439241?lang=zh_cn&edition=full","pubTime":"2025-11-21 21:03","pubTimestamp":1763730184,"startTime":"0","endTime":"0","summary":"证券之星消息,根据11月21日市场公开信息、上市公司公告及交易所披露数据整理,康泰医学最新董监高及相关人员股份变动情况:2025年11月20日公司董事,高管杨志山、董秘,高管郑敏、高管寇国治、高管许云龙共减持公司股份4000.0股,占公司总股本为0.0008%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112100037414.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300869"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2584131062","title":"康泰医学:11月19日高管寇国治减持股份合计5.9万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2584131062","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584131062?lang=zh_cn&edition=full","pubTime":"2025-11-20 21:03","pubTimestamp":1763643781,"startTime":"0","endTime":"0","summary":"证券之星消息,根据11月20日市场公开信息、上市公司公告及交易所披露数据整理,康泰医学最新董监高及相关人员股份变动情况:2025年11月19日公司高管寇国治共减持公司股份5.9万股,占公司总股本为0.0147%。康泰医学近半年内的董监高及核心技术人员增减持详情如下:康泰医学的高管列表及最新持股情况如下:融资融券数据显示该股近5日融资净流入619.14万,融资余额增加;融券净流入0.0,融券余额增加。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112000036031.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2584949077","title":"康泰医学:11月18日高管寇国治、付春元减持股份合计42万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2584949077","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584949077?lang=zh_cn&edition=full","pubTime":"2025-11-19 21:03","pubTimestamp":1763557380,"startTime":"0","endTime":"0","summary":"证券之星消息,根据11月19日市场公开信息、上市公司公告及交易所披露数据整理,康泰医学最新董监高及相关人员股份变动情况:2025年11月18日公司高管寇国治、高管付春元共减持公司股份42.0万股,占公司总股本为0.1046%。康泰医学近半年内的董监高及核心技术人员增减持详情如下:康泰医学的高管列表及最新持股情况如下:融资融券数据显示该股近5日融资净流入413.45万,融资余额增加;融券净流入0.0,融券余额增加。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111900037701.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300869"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2584162564","title":"康泰医学:11月14日高管付春元减持股份合计2万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2584162564","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584162564?lang=zh_cn&edition=full","pubTime":"2025-11-17 21:03","pubTimestamp":1763384636,"startTime":"0","endTime":"0","summary":"证券之星消息,根据11月17日市场公开信息、上市公司公告及交易所披露数据整理,康泰医学最新董监高及相关人员股份变动情况:2025年11月14日公司高管付春元共减持公司股份2.0万股,占公司总股本为0.005%。康泰医学近半年内的董监高及核心技术人员增减持详情如下:康泰医学的高管列表及最新持股情况如下:融资融券数据显示该股近5日融资净流入825.03万,融资余额增加;融券净流入0.0,融券余额增加。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111700034085.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300869"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2583159837","title":"康泰医学:11月12日高管付春元减持股份合计4.48万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2583159837","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583159837?lang=zh_cn&edition=full","pubTime":"2025-11-13 21:03","pubTimestamp":1763039012,"startTime":"0","endTime":"0","summary":"证券之星消息,根据11月13日市场公开信息、上市公司公告及交易所披露数据整理,康泰医学最新董监高及相关人员股份变动情况:2025年11月12日公司高管付春元共减持公司股份4.48万股,占公司总股本为0.0111%。康泰医学近半年内的董监高及核心技术人员增减持详情如下:康泰医学的高管列表及最新持股情况如下:融资融券数据显示该股近5日融资净流入610.66万,融资余额增加;融券净流入0.0,融券余额增加。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111300040378.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2582614783","title":"康泰医学:11月10日高管付春元减持股份合计5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2582614783","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582614783?lang=zh_cn&edition=full","pubTime":"2025-11-11 21:03","pubTimestamp":1762866201,"startTime":"0","endTime":"0","summary":"证券之星消息,根据11月11日市场公开信息、上市公司公告及交易所披露数据整理,康泰医学最新董监高及相关人员股份变动情况:2025年11月10日公司高管付春元共减持公司股份5.0万股,占公司总股本为0.0124%。康泰医学近半年内的董监高及核心技术人员增减持详情如下:康泰医学的高管列表及最新持股情况如下:融资融券数据显示该股近5日融资净流入253.91万,融资余额增加;融券净流入0.0,融券余额增加。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111100038481.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2582879208","title":"康泰医学:11月7日高管付春元减持股份合计4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2582879208","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582879208?lang=zh_cn&edition=full","pubTime":"2025-11-10 21:03","pubTimestamp":1762779793,"startTime":"0","endTime":"0","summary":"证券之星消息,根据11月10日市场公开信息、上市公司公告及交易所披露数据整理,康泰医学最新董监高及相关人员股份变动情况:2025年11月7日公司高管付春元共减持公司股份4.0万股,占公司总股本为0.01%。康泰医学近半年内的董监高及核心技术人员增减持详情如下:康泰医学的高管列表及最新持股情况如下:融资融券数据显示该股近5日融资净流出160.3万,融资余额减少;融券净流入0.0,融券余额增加。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111000032390.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1775991855380,"stockEarnings":[{"period":"1week","weight":0.0198},{"period":"1month","weight":-0.0709},{"period":"3month","weight":-0.1624},{"period":"6month","weight":-0.1854},{"period":"1year","weight":0.04},{"period":"ytd","weight":-0.1093}],"compareEarnings":[{"period":"1week","weight":0.0274},{"period":"1month","weight":-0.0356},{"period":"3month","weight":-0.0326},{"period":"6month","weight":0.0229},{"period":"1year","weight":0.2366},{"period":"ytd","weight":0.0044}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"康泰医学系统(秦皇岛)股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"34665人(较上一季度增加11.54%)","perCapita":"7619股","listingDate":"2020-08-24","address":"河北省秦皇岛市海港区经济技术开发区秦皇西大街112号","registeredCapital":"40180万元","survey":" 康泰医学系统(秦皇岛)股份有限公司的主营业务是医疗诊断、监护设备的研发、生产和销售。公司的主要产品是院线类产品、家用类产品、其他类产品。截至报告期末,公司及子公司共获得国内外有效专利484项,计算机软件著作权369项以及大量的技术储备。研发创新能力已经成为公司的核心竞争力之一。2025年4月,由河北工业大学牵头,复旦大学、燕山大学、康泰医学联合完成的“具身运动康复智能装备关键技术与应用”项目成果获得2024年度河北省科技进步奖一等奖。","listedPrice":10.16},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康泰医学(300869)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康泰医学(300869)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康泰医学,300869,康泰医学股票,康泰医学股票老虎,康泰医学股票老虎国际,康泰医学行情,康泰医学股票行情,康泰医学股价,康泰医学股市,康泰医学股票价格,康泰医学股票交易,康泰医学股票购买,康泰医学股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康泰医学(300869)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康泰医学(300869)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}